In this study, a platinum (II) complex ([Pt (H2L)(PPh3)] complex) containing a
thiocarbohydrazone as the ligand was tested as an anti-proliferative agent against ovarian …

Drug repurpose or reposition has been recently recognized as a high‐performance strategy
for develo** therapeutic agents for cancer treatment. This approach can significantly …

Seven novel azo dyes with 2-pyridone and dihydropyrimidinone moieties have been
synthesized and thoroughly characterized. The azo-hydrazone tautomerism has been …

Abstract The complex [Pt (AEP) Cl 2]; C-1 (where, AEP= 1-(2-Aminoethyl) pyrrolidine) and its
hydrolyzed diaqua form cis-[Pt (AEP)(H 2 O) 2] 2+; C-2 were synthesized for their bioactivity …

A urea-functionalized chemoreceptor 1, 5-bis (2, 4-dinitrophenyl) carbonohydrazide (BDC)
with versatile applications has been reported in this work. BDC displayed ditopic sensitivity …

Abstract A dinuclear Cu II-Gd III Schiff base complex (a di-compartmental Schiff base ligand
derived from o-vanillin) nominated as: 1, 3-propanediyl-bis (2-iminomethylene-6-methoxy …

With the incessant rise in the cancer burden worldwide it is a dire need to develop
anticancer agents that will offer negligible or no side effects and at the same time will be …

The present study deals with design and synthesis of new mononuclear Cu (II), Co (II), Ni (II)
and Zn (II) metal complexes of hydrazone of 2-(2-(2, 4-dihydroxybenzylidene) …

Treatments of N-(pyridin-2-ylmethyl) pyrazine-2-carboxamide (L1), N-(quinolin-8-yl)
pyrazine-2-carboxamide (L2), N-(quinolin-8-yl) picolinamide (L3) and N-(quinolin-8-yl) …

Abstract Cis‐[Pt (TEEDA) Cl2]; 1 (where TEEDA= N, N, N′‐triethylethylenediamine) was
synthesised, and its SCXRD structure was determined. Complex 1 crystallises in the …